Wardwizard Healthcare Ltd

Wardwizard Healthcare Limited: Trading window closed from 01 October 2026 till forty-eight (48) hours after the Declaration/ Publication of Unaudited Standalone Financial Results for the Second Quarter and Half Year ended on 30th September, 2026.

AGM details

• Date: 30 September 2026; Time: 03:00 PM IST; Mode: VC/OAVM.

Key resolutions

• Resolution: Special business to approve promoter-group investment via preferential issue.
• Proposed investment size: Rs 8 crore for 2% non-cumulative convertible preference shares.
• Purpose: fund hospital growth and expansion by the investee.
• Use of proceeds: exclusively for the investee; not for other promoter entities.
• RPT context: relates to promoter-group investment; subject to regulatory approvals.
• Restatement clarifies object per BSE query.

Appointment: Sathi Kundu

• Ms. Sathi Kundu appointed as Additional Independent Woman Director, effective 31 August 2026, for 5-year term.

Appointment: Yuvraj Priyadarshi as Whole-Time Director

• Mr. Yuvraj Priyadarshi appointed Whole-time Director, effective 30 September 2026, for 5-year term, subject to shareholders' approval.

Warrant issue details

• Instrument: Fully convertible warrants issued on a private placement basis.
• Size: Up to 12.50 crore for up to 12,500,000 warrants.
• Price: ₹10 per warrant, convertible into equity shares at par.
• Conversion: 1 warrant converts into 1 equity share; exercisable within 18 months.
• Lapse: Unexercised warrants lapse; amounts paid forfeited.
• Promoter allottees: Yatin Gupte (post-issue 41.51%), Sheetal Bhalerao (14.40%).
• Non-promoter allottees: post-issue holdings range 1.57% to 4.94%.
• Use of proceeds: Growth, expansion, working capital, and investment in promoter group entities.
• Terms: Warrants convertible in one or more tranches within 18 months.

Capital changes and warrant issue

• Authorized share capital increased to Rs 25 crore; MOA Clause V updated.
• Up to 1,25,00,000 fully convertible warrants issued on private placement at Rs 10 each.
• Warrants convertible within 18 months; unconverted warrants lapse.
• Proceeds to fund growth, expansion, working capital; includes investment in Wardwizard Medicare Pvt Ltd.
• Annexures A–C provide detailed disclosures and appointment information.

Directors and key management appointments

• Ms. Sathi Kundu appointed as Additional Independent Woman Director from 31 Aug 2026; shareholder approval required.
• Yuvraj Priyadarshi appointed Whole Time Director from 30 Sep 2026 for five years; subject to approval.
• Re-appointment of Yatin Sanjay Gupte as Non-Executive, Non-Independent director recommended.

AGM and governance notices

• 42nd AGM scheduled for 30 Sep 2026 at 3:00 PM via VC/OAVM; e-voting 27–29 Sep.
• Register of Members closed from 23–30 Sep 2026.
• Kamal A Lalani appointed Scrutinizer for AGM e-voting.
• NSDL e-voting and VC/OAVM facility available for AGM.

Regulatory disclosures and annexures

• Annexure A contains SEBI LODR disclosures on warrants; Annexures B and C cover appointments.
• Annexure A includes detailed warrant information; other annexures summarize appointments.

Wardwizard Healthcare Ltd trading window closed from 24.08.2026 until 48 hours after the declaration of the outcome of the Board Meeting scheduled to be held on 31.08.2026

Meeting Details

• Board meeting scheduled on 31 August 2026; time and venue not disclosed.

Key Agenda Items

• Proposal for raising further capital through equity shares and linked instruments via various modes.
• Increase in Authorized Share Capital and alteration of the Memorandum of Association Capital Clause.
• Any other matter with the chair's approval.

Other Notes

• Trading window closed from 24 August 2026 until 48 hours after board outcome.